Covestor LTD Iveric Bio, Inc. Transaction History

Covestor LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$26.24 - $39.63 $42,325 - $63,923	1,613 Added 17922.22%	1,622 $63,000
Q4 2022 Feb 13, 2023	SELL	$17.24 - $23.95 $120 - $167	-7 Reduced 43.75%	9 $0
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $18 - $37	-2 Reduced 11.11%	16 $0
Q2 2022 Aug 10, 2022	SELL	$9.12 - $18.9 $54 - $113	-6 Reduced 25.0%	18 $0
Q1 2022 May 13, 2022	SELL	$12.15 - $16.83 $60 - $84	-5 Reduced 17.24%	24 $0
Q4 2021 Feb 10, 2022	BUY	$13.83 - $18.78 $401 - $544	29 New	29 $0

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.